₹ 48.45
0.00 (0.00%)
BSE
O
Oxygenta Pharmaceutical
₹ 48.45
BSE
Oxygenta Pharmaceutical Fundamentals
Company Valuation
Market Cap (₹ Cr.)
179
PE Ratio
-13.20
PB Ratio
-4.20
Dividend Yield
-
ROE
41.16%
ROCE
-51.82%
Book Value (₹)
-11.54
Face Value (₹)
10.00
Analyse OXYGENTAPH with 12+ custom fundamentals and financial ratios.
Share Holding Pattern
| Held By | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|---|
| Promoters | 57.95% | 55.93% | 56.54% | 56.54% | 56.54% |
| Domestic Institutional Investors (DII) | 0.03% | 0.03% | 0.03% | 0.03% | 0.03% |
| Foreign Institutional Investors (FII) | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Investors | 36.55% | 38.90% | 38.12% | 38.16% | 38.27% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
OXYGENTAPH Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals & Biotechnology
Company Classification
Microcap
BSE Scrip Code
524636
NSE Scrip Name
OXYGENTAPH
ISIN
INE102E01018

Pay Zero Brokerage on Delivery
Open FREE Demat Account
+91
Or Scan the QR Code to download the Dhan App






